Genzyme receives company award from European Organisation for Rare Diseases
27 February 2013 | By Genzyme
Sanofi and its subsidiary Genzyme announced today that Genzyme has received a Company Award from EURORDIS...
List view / Grid view
News
Join Lonza’s March webinar on endotoxin detection methods
There are many Limulus Amebocyte Lysate (LAL) methods commercially available today. Hence, Lonza is hosting a free, 60-minute webinar entitled "Endotoxin Detection – Which Method Is Best for Me" at two different dates and times.
Academy and Alzheimer’s Drug Discovery Foundation award challenge grant for research of biomarkers in Alzheimer’s disease
26 February 2013 | By The New York Academy of Sciences
The Academy awarded a challenge grant...
Roche launches new process for accessing clinical trial data
26 February 2013 | By Roche
Independent body to grant access to patient-level data for scientific review...
AstraZeneca announces results from long-term safety trial of naloxegol in patients with opioid-induced constipation
26 February 2013 | By AstraZeneca
AstraZeneca announced high-level results from KODIAC-08...
Novartis reports Phase III data showing omalizumab improved itch in patients with a chronic form of hives who failed standard therapy[1]
24 February 2013 | By Novartis
Late-breaking results from ASTERIA II...
Phase III results: tiotropium* Respimat® is effective in symptomatic asthma patients irrespective of their allergic status
23 February 2013 | By Boehringer Ingelheim
New Phase III data presented...
European Medicines Agency recommends approval of Hexyon/Hexacima 6-in-1 pediatric vaccine
22 February 2013 | By Sanofi
The EMA recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine...
FDA approves Roche’s Kadcyla (trastuzumab emtansine)
22 February 2013 | By Roche
New personalised medicine helped people in Phase III study live longer, compared to standard treatment...
Tecan microarray solutions transform functional proteomics workflows at ASU
21 February 2013 | By kdm communications
“We have adopted a unique approach to functional proteomics..."
ARIAD announces appointment of European General Manager and other key members of leadership team
21 February 2013 | By Biosector 2
ARIAD announced the appointment of Jonathan E. Dickinson...
New findings from two studies support substantial benefit of Pradaxa® for prevention of recurrent deep vein thrombosis and pulmonary embolism
21 February 2013 | By Boehringer Ingelheim
Findings from two trials...
Abbott to collaborate with Janssen and Pharmacyclics
21 February 2013 | By Abbott
Abbott will collaborate with Janssen Biotech and Pharmacyclics to explore the benefits of Abbott's proprietary FISH technology...
Announcement of application for approval in Japan of DPT-IPV vaccine
20 February 2013 | By Daiichi Sankyo
DPT-IPV vaccine for prevention of Diphtheria, Pertussis, Tetanus, and acute Poliomyelitis...
Phase 3 data shows bendamustine plus rituximab doubles progression-free survival in patients with iNHL and MCL compared with CHOP-R
Results from the StiL NHL-1 study...
